This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects.
Clinical trial NCT07676669 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07676669
- Sponsor
- Watim Medical & Dental College
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2027-03-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.